This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

 

MGuard Prime

 

Titan-2

 

 

Bioresorbable Stents

 

Drawbacks of Bioresorbable Polymeric Stents

 

Selected Bioresorbable Coronary Stents

The Absorb stent

 

Biotronik's Dreams stent

 

DESolve stent

 

ReZolve Stent

 

IDEAL stent

 

Other bioresorbable stents

 

 

 

Lesion Specific Stents

Dedicated Bifurcated Stents

Axxess

 

Nile Pax

 

Stentys Self-Apposing stent

 

Taxus Petal

 

Xience Side Branch Access

 

Sparrow

 

Taxus Liberte Atom

 

Xience nano

 

 

 

CHAPTER FIVE: INDUSTRY STRUCTURE & TRENDS

Sales and Marketing Capabilities

 

Differentiation Strategies

Improved Stent Materials

 

Reduced DAPT Duration

 

 

Lesion-Specific Stents

Extended Indications

 

 

Significant Trends In The Coronary Stents Market

 

 

Market Drivers

New devices Expanded Indications

Acute Myocardial Infarction and Diabetes

 

 

Emerging Markets Are Expected To Spur The Overall Market Growth.

 

 

Market Restraints

Price decline hampers growth in the overall market.

 

Cost Constraints

 

Difficult Economic Conditions

 

 

Notable Recent Industry Events

Recent Mergers and Acquisitions

Biosensors International acquired CardioMind and Devax

 

Medtronic Acquired Invatec

 

Xenogenics Corporation Acquired Bioabsorbable Therapeutics

 

 

Market Exits

 

 

CHAPTER SIX: MARKET REVENUES AND FORECAST

 

Market by Type of Stent

Drug Eluting Stents Market

Market Snapshot

 

 

Products Analysis

Xience V

 

Promus Element/Plus

 

Resolute Integrity

 

Market Dynamics in the Drug-Eluting Stents Segment

 

 

 

Revenue Forecast

Bare Metal Stents Market

Market Snapshot

 

Market Dynamics

 

Revenue Forecast

 

 

United States

Market Snapshot

 

Revenue Forecast

 

 

Europe

Market snapshot

 

Revenue Forecast

 

 

Japan

Market snapshot

 

Revenue forecast

 

 

China

Market Snapshot

 

Revenue forecast

 

 

India

Market snapshot

 

Revenue Forecast

 

 

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs